Stockreport

Pyxis Oncology GAAP EPS of -$1.28 misses by $0.93, revenue of $13.9M [Seeking Alpha]

Pyxis Oncology, Inc.  (PYXS) 
PDF As of December 31, 2025, Pyxis Oncology had cash and cash equivalents, including restricted cash, and short-term investments, of $68.3 million. The Company believes tha [Read more]